Health Care
IDEXX Laboratories posted higher Q2 FY2026 revenue and net income, led by strong CAG diagnostics recurring sales and broad margin improvement.
Key risk: Macroeconomic and Geopolitical Uncertainty
Global conflicts, inflationary pressures, and economic downturns could reduce pet owner spending on veterinary services and products, while also raising operating costs for IDEXX.
Other Health Care Equipment companies